The New York-based law firm, known for pursuing securities fraud claims, invited current FBIO investors to participate in an evaluation of the company’s governance practices. Joseph E. Levi, lead attorney on the case, confirmed the firm is collecting information to determine if management’s actions harmed shareholder value. The investigation focuses on whether those in control of Fortress Biotech failed to act in the best interests of their investors.

While the firm has a history of litigating high-stakes financial cases, they emphasized that this inquiry carries no immediate cost or obligation for participating shareholders. Investors seeking to provide information or learn more about the potential claim can reach the firm at 212-363-7500 or via their online portal. Fortress Biotech has not yet responded to the inquiry, which marks a recurring trend of legal firms probing corporate oversight in the biotech sector.